Code Clarity

When is a medicine… not a medicine — at least according to the PMCPA? 🤔In this episode, we dig into a fascinating case ( AUTH/3880/2/24 ) where the ruling found no promotion of a medicine on social media. What crossed the line, what didn’t and what does it mean for your next post?

Speakers confirmed, slides ready… but no one shows up. 😬What do you do when a pharma meeting has no audience? Cancel? Pay? Re-run? We chat through compliance, optics and common-sense calls in this scenario.

The PMCPA says (currently) most complaints still stem from social media - and they’re now hinting at a cease-and-desist approach. We unpack what that could mean for pharma whilst everyone is still guessing what “promotional” really means...

It seems the PMCPA's review on defining Medical Education is freezing up ❄️. With the PMCPA’s influence possibly shaping European guidance, and post-Brexit UK now charting its own stricter course, is this the moment to rethink how “medical education” and “promotion” are defined, and what it means for pharma on both sides of the Channel?

Declarations of involvement are causing drama! But they are an easy target which means a quick win for pharma too. We discuss the 5 point-plan the PMCPA don't want you to know - more of this at our conference .

Two PMCPA rulings (one old , one recent ) about an "innocent" drink but involving pharma customers. A casual thank-you or a full-blown breach? Our conference on 4 Nov will discuss commercial push, medical pull and compliance risks.

SOME say UK pharma has “a slow self-regulatory process that fails to ensure compliance” (BMJ letter, Oct 23) WE say it is the PMCPA themselves bringing the industry into disrepute (evidence to be presented at conference) 🛠️What do YOU say? Does self-regulation need fixing? 🎤 Join the conference debate

Another day, another email & another PMCPA case. Can we blame Brexit for Global forgetting the UK is no longer in the EU? Can 21 emails in 3 months ever not be spam? We'll explore how medical publishers can get ahead of pharma's needs. (Case Auth/ 3860/12/23 , 3862/12/23 , 3866/12/23 & 3889/4/24 )

Waiting for the PMCPA to audit your company? In this episode, we unpack why proactive compliance audits beat reactive panic, how they foster a healthy culture, and how to turn findings into solid CAPAs - not just a pile of paperwork!

It’s the detail that matters. Moderna skips over the nitty-gritty and the Appeal Board isn’t having any of it. Rina & Jean look at what happens when you serve generalities instead of granularity. (Case AUTH/0316/10/24 & 3835/10/23 .)(3/3)

Moderna responds to a PMCPA complaint... but forgets one crucial ingredient: *all the details*. We explore why being “not-so-full and not-so-frank” came back to bite and led to an audit. ( Case AUTH/0316/10/24 .) (2/3)

Can a “views are my own” disclaimer really save you from the PMCPA’s watchful eye? Spoiler: no. Moderna learns this the hard way. ( Case Auth/ 3835/10/23 ) (1/3)

Rina & Jean dive into the drama of a recent confession by Pierre Fabre & the results of our audience poll... asking the big question: should voluntary admissions come with a checklist… or at least a decent apology template?

The ABPI has recently published guidance on congresses. What does the Code already say on this topic? What does the Guidance include? And what does it all mean. Code Clarity is hosting a webinar on this topic on 6th May 2025, 12.30-1.30pm. Contact us at hello@codeclarity.co.uk for more details.

Jean and Rina discuss a recent case about something said by a Celltrion sales rep - top tips relate to why it's important to prove what you say in calls is correct!

Our poll suggests 85% of you want the QR code to link to SPC OR for HCPs to refer to the SPC. So is this the beginning of the end for Prescribing Information?

A recent case about a gay dating app confirms WHEN the UK Code applies and WHY appeals are worth it.

Yay, a Complaints Masterclass to increase your confidence when it comes to self-regulation - from experts in complaints management! Register your interest: hello@codeclarity.co.uk (15th May 2025, 1.30-4.30pm, Woburn House, London, WC1H 9HQ)

An update on case rulings that may affect the way UK Pharma can do Medical Education - what's changed and what can we learn? Cases discussed are AUTH/3832/10/23 and AUTH/3825/9/23

Recent news about Astellas merging C-suite roles (medical and commercial) - what's the fuss about? And top tips if you're considering the same.

Rina & Jean discuss a recent appeal by Janssen relating to UK speakers presenting at international meetings - why was the appeal so good?!

Becs Shuttleworth joins Rina & Jean to explain the importance of bringing compliance into the light.

Yay the first abridged procedure case vs CSL Seqirus has been published ! A dull case but Rina covers the 2 interesting points to take away

Oh dear - an employee of a competitor company lobs a rubbish complaint to the PMCPA and wow - they have to accept, as it's non-contactable. MADNESS.

How to influence Code changes (yes it can be done!) & tips about the practical implementation of QR Codes with Jenni Harrison and Richard Blackwell. If you need confidence, here's a link to our compliance checklist on QR codes.